Depression Clinical Trial
Official title:
Parkinson's Disease Depression and tDCS
Verified date | May 2018 |
Source | Pacific Parkinson's Research Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Parkinson's disease (PD) is a progressive neurological disease that has effects on both movement and mental health. One of the most common mental health complications of PD is depression. Up to 30% of Parkinson's patients will experience depression at some point. We aim to investigate whether transcranial direct current stimulation (tDCS), a type of electrical stimulation for the brain, can improve depression in PD as well as improve motor function in PD.
Status | Terminated |
Enrollment | 3 |
Est. completion date | December 6, 2017 |
Est. primary completion date | December 6, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: 1. are outpatients, 2. are voluntary and competent to consent to treatment, 3. have a Mini-International Neuropsychiatric Interview (MINI) confirmed diagnosis of major depressive disorder (MDD), 4. have a diagnosis of PD according to the UK PD brain bank criteria, 5. are 19 years of age or more, 6. have a score > 13 on the Beck Depression Inventory-II (BDI-II), 7. still have depressive symptoms after 6 weeks or more of antidepressant (SSRI) medication treatment (and on a stabilized dose of at least 4 weeks), 8. are able to adhere to the treatment schedule, 9. are proficient in written and verbal English. Exclusion Criteria: 1. have a history of substance dependence or abuse within the last 6 months, 2. have a concomitant significant unstable medical illness, 3. have active suicidal intent, 4. have any history of seizure or medication-resistant epilepsy in the family, 5. have a lifetime Mini-International Neuropsychiatric Interview (MINI) diagnosis of bipolar I or II disorder, schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, or current psychotic symptoms 6. have a MINI diagnosis of obsessive compulsive disorder, post-traumatic stress disorder (current or within the last year), anxiety disorder (generalized anxiety disorder, social anxiety disorder, panic disorder), or dysthymia, assessed by a study investigator to be primary and causing greater impairment than MDD, 7. have failed a course of ECT in the current episode or previous episode, 8. have received tDCS or other neurostimulation therapy for any previous indication due to the potential compromise of expectancy effects, 9. have any significant neurological disorder or insult including, but not limited to: any condition likely to be associated with increased intracranial pressure, space occupying brain lesion, any history of seizure except those therapeutically induced by ECT, cerebral aneurysm, Huntington's chorea, multiple sclerosis, significant head trauma with loss of consciousness for greater than or equal to 5 minutes, or developmental disorder, 10. have an intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed, 11. are taking a non-SSRI antidepressant medication, 12. are pregnant (women of childbearing age only). Exclusion Criteria for PET: 1. unable to tolerate staying off anti-parkinsonian medication for 12-18 hours pre-PET scan, 2. have a history of radiation therapy treatment or other high amounts of radiation. Exclusion Criteria for MRI: - Artificial heart valve; - Brain aneurysm clip; - Electrical stimulator for nerves or bones; - Ear or eye implant; - Implanted drug infusion pump; - Coil, catheter, or filter in any blood vessel; - Orthopedic hardware (artificial joint, plate, screws); - Other metallic prostheses; - Shrapnel, bullets, or other metal fragments; - Surgery or tattoos (including tattooed eyeliner) in the last six weeks. |
Country | Name | City | State |
---|---|---|---|
Canada | Pacific Parkinson's Research Centre | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Pacific Parkinson's Research Centre |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HAMD score | an assessment of the severity of depression | 12 weeks | |
Secondary | Dopamine levels | PET scanning will be used to assess dopamine levels before and after sham/active tDCS in 20 participants | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |